Inhibikase Therapeutics

NasdaqCM:IKT Stock Report

Mkt Cap: US$23.0m

Inhibikase Therapeutics Company Information

Inhibikase Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Inhibikase Therapeutics, Inc.
  • Ticker: IKT
  • Exchange: NasdaqCM
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$22.957m
  • Shares outstanding: 25.23m
  • Website:

Number of Employees


  • Inhibikase Therapeutics, Inc.
  • 3350 Riverwood Parkway SE
  • Suite 1900
  • Atlanta
  • Georgia
  • 30339
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IKTNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDDec 2020
IQTDB (Deutsche Boerse AG)YesCommon StockDEEURDec 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/30 00:00
End of Day Share Price2022/09/30 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.